Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Nuclear Imaging Devices Market Analysis

ID: MRFR/HC/6542-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

Nuclear Imaging Devices Market Research Report By Application (Cardiology, Oncology, Neurology, Thyroid Function), By Product Type (Single Photon Emission Computed Tomography, Positron Emission Tomography, Hybrid Imaging Systems), By End Use (Hospitals, Diagnostic Centers, Research Institutions), By Technology (Cobalt-60, Technetium-99m, Gallium-68) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Nuclear Imaging Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Nuclear Imaging Devices Market Industry Landscape

The market dynamics of nuclear imaging devices are characterized by continuous advancements in medical technology and increasing prevalence of chronic diseases. Nuclear imaging plays a crucial role in diagnosing and monitoring various medical conditions, driving the demand for these devices. The world wide rise in chronic diseases such as cancer and cardiovascular problems has vastly led to the development of the nuclear imaging devices market. Such hardware assists in early identification, accurate identification, and efficient treatment of such situations for a growing acceptance. Technological advancements and subsequent advances in the field of nuclear imaging have driven the market tremendously. Improvements in the resolution of imaging, coincidently lowering radiation exposure and the emergence of hybrid imaging, such as PET/ CT, has improved the accuracy and speed of diagnostic techniques. With the increasing aged population of the world, age-related diseases have become furthermore common which doesn’t allow to use simply today’s standard tools. The aging population formulates a niche market for imaging devices and nuclear imaging devices are used in diagnosing condition which are occurring more in the elderly thus driving the market. Many governments and private sector bodies are spending hefty amounts to improve the healthcare infrastructure, especially in th erection of newer generation imaging apparatus. This increased from infrastructure development is beneficial not only for the nuclear imaging devices market but for the market itself as it allows for accessibility and affordability. With improved consciousness in the medics as well as patients of the advantages of nuclear imaging, demand has also enhanced. With an increasing appreciation of the benefits of early ac- curate diagnosis, the market for nuclear imaging devices is likely to experience continued growth. The regulatory landscape and reimbursement factors come into play when naming the forces influencing the dynamics of the nuclear imaging devices market. Rigorous regulatory standards guarantee safety and efficacy of these devices, also favorable reimbursement policies assist uptake. There is an increasing trend of industry – academic – healthcare partnerships. Such alliances promote the growth of novel technologies and the diffusion of market range outlets, contributing to the competitive and dynamic market. Although the development trends are favorable, factors of limitations are high initial setup costs, apprehensions regarding radiation exposure and availability of other diagnostic modalities can slow down the market growth to a greater extent. Though this challenge of sustaining strong market growth need to be dealt with by looking into research and development, it seems that these issues would remain pressing ones. The nuclear imaging devices market is poised for further growth with ongoing research, technological advancements, and a focus on personalized medicine. The integration of artificial intelligence in nuclear imaging is a notable trend, promising to enhance diagnostic accuracy and efficiency in the coming years.

Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Nuclear Imaging Devices Market by 2035?

<p>The projected market valuation for the Nuclear Imaging Devices Market by 2035 is 3.174 USD Billion.</p>

What was the market valuation of the Nuclear Imaging Devices Market in 2024?

<p>The overall market valuation of the Nuclear Imaging Devices Market was 1.98 USD Billion in 2024.</p>

What is the expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035 is 4.38%.</p>

Which application segment had the highest valuation in the Nuclear Imaging Devices Market in 2024?

<p>In 2024, the Cardiology and Oncology application segments each had a valuation of 0.792 USD Billion.</p>

What are the key players in the Nuclear Imaging Devices Market?

<p>Key players in the Nuclear Imaging Devices Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.</p>

Which product type is projected to dominate the Nuclear Imaging Devices Market?

<p>The Single Photon Emission Computed Tomography product type is projected to dominate the Nuclear Imaging Devices Market with a valuation of 0.792 USD Billion in 2024.</p>

What is the valuation of the Diagnostic Centers segment in the Nuclear Imaging Devices Market?

<p>The Diagnostic Centers segment had a valuation of 0.66 USD Billion in 2024.</p>

Which technology segment is expected to see significant growth in the Nuclear Imaging Devices Market?

<p>The Technetium-99m technology segment is expected to see significant growth, with a valuation of 1.0 USD Billion in 2024.</p>

How does the market valuation of Research Institutions compare to that of Hospitals in 2024?

<p>In 2024, the market valuation for Hospitals was 0.99 USD Billion, while Research Institutions had a valuation of 0.33 USD Billion.</p>

What is the projected growth trend for the Nuclear Imaging Devices Market in the coming years?

<p>The Nuclear Imaging Devices Market is expected to grow steadily, reaching a valuation of 3.174 USD Billion by 2035.</p>

Market Summary

As per Market Research Future analysis, the Nuclear Imaging Devices Market Size was estimated at 1.98 USD Billion in 2024. The Nuclear Imaging Devices industry is projected to grow from 2.067 USD Billion in 2025 to 3.174 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.38% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Nuclear Imaging Devices Market is poised for substantial growth driven by technological advancements and increasing demand for early diagnosis.

  • Technological advancements are enhancing the capabilities of nuclear imaging devices, leading to improved diagnostic accuracy. The growing demand for early diagnosis is propelling the adoption of nuclear imaging technologies across various healthcare settings. North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for nuclear imaging devices. Key market drivers include the increasing prevalence of chronic diseases and the rising geriatric population, which are fueling the need for advanced imaging solutions.

Market Size & Forecast

2024 Market Size 1.98 (USD Billion)
2035 Market Size 3.174 (USD Billion)
CAGR (2025 - 2035) 4.38%
Largest Regional Market Share in 2024 North America

Major Players

<a href="https://www.gehealthcare.com/products/molecular-imaging/nuclear-medicine?srsltid=AfmBOoplYGa6tVvO5mbcJTgBbcW7oNdMb8gh-BzCzQvxxeOMEjiW5MtE">GE Healthcare </a>(US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT), Lantheus Medical Imaging (US)

Market Trends

The Nuclear Imaging Devices Market is currently experiencing a transformative phase, driven by advancements in technology and increasing demand for precise diagnostic tools. The integration of artificial intelligence and machine learning into imaging devices appears to enhance the accuracy and efficiency of nuclear imaging procedures. Furthermore, the growing prevalence of chronic diseases necessitates early detection and monitoring, which nuclear imaging facilitates effectively. As healthcare systems evolve, the emphasis on personalized medicine and patient-centric approaches is likely to propel the adoption of these devices, fostering innovation and expanding market reach. In addition, the rising awareness of the benefits associated with nuclear imaging, such as its non-invasive nature and ability to provide functional information about organs, suggests a positive trajectory for the market. Collaborations between manufacturers and healthcare providers may further enhance the development of advanced imaging solutions. Overall, the Nuclear Imaging Devices Market seems poised for growth, driven by technological advancements and an increasing focus on improving patient outcomes.

Technological Advancements

Recent innovations in imaging technology, particularly in detector materials and software algorithms, are enhancing the performance of nuclear imaging devices. These advancements may lead to improved image quality and reduced radiation exposure for patients.

Growing Demand for Early Diagnosis

The increasing prevalence of chronic diseases is driving the need for early and accurate diagnostic tools. Nuclear imaging devices are becoming essential in identifying conditions at earlier stages, which could potentially improve treatment outcomes.

Focus on Personalized Medicine

The shift towards personalized medicine is influencing the Nuclear Imaging Devices Market. Tailored imaging solutions that cater to individual patient needs are likely to gain traction, promoting the development of specialized imaging techniques.

Nuclear Imaging Devices Market Market Drivers

Rising Geriatric Population

The increasing geriatric population is a significant factor influencing the Nuclear Imaging Devices Market. As individuals age, the likelihood of developing chronic diseases escalates, leading to a higher demand for diagnostic imaging services. The elderly population often requires more frequent medical evaluations, including imaging studies, to monitor health conditions. This demographic shift is prompting healthcare providers to invest in advanced nuclear imaging technologies to cater to the needs of older patients. Projections indicate that the global population aged 65 and older will double by 2050, which could substantially increase the demand for nuclear imaging devices. Consequently, the market is poised for growth as healthcare systems adapt to this demographic trend.

Growing Awareness of Early Diagnosis

There is a notable increase in awareness regarding the importance of early diagnosis in the management of diseases, which is driving the Nuclear Imaging Devices Market. Patients and healthcare professionals alike recognize that early detection can significantly improve treatment outcomes and survival rates. This awareness is leading to a higher utilization of nuclear imaging techniques, which are known for their ability to detect diseases at earlier stages. As educational initiatives and public health campaigns promote the benefits of early diagnosis, the demand for nuclear imaging devices is likely to surge. This trend suggests a robust growth trajectory for the market, as more healthcare facilities incorporate nuclear imaging into their diagnostic protocols.

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure, particularly in emerging economies, is a crucial driver for the Nuclear Imaging Devices Market. As countries invest in healthcare facilities and services, the demand for advanced diagnostic tools, including nuclear imaging devices, is expected to rise. Improved access to healthcare services and increased funding for medical technologies are facilitating the adoption of nuclear imaging in various clinical settings. This expansion is not only enhancing diagnostic capabilities but also improving patient care. The Nuclear Imaging Devices Market stands to benefit from this trend, as more healthcare providers seek to integrate advanced imaging technologies into their practices, thereby driving market growth.

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a primary driver for the Nuclear Imaging Devices Market. As these diseases become more prevalent, the demand for advanced diagnostic tools increases. Nuclear imaging techniques, including PET and SPECT, are essential for accurate diagnosis and treatment monitoring. According to recent data, the number of cancer cases is projected to rise significantly, necessitating enhanced imaging solutions. This trend indicates a growing market for nuclear imaging devices, as healthcare providers seek effective methods to diagnose and manage chronic illnesses. The Nuclear Imaging Devices Market is thus positioned to expand, driven by the urgent need for reliable diagnostic technologies.

Technological Innovations in Imaging Techniques

Technological advancements in nuclear imaging techniques are transforming the Nuclear Imaging Devices Market. Innovations such as hybrid imaging systems, which combine PET and CT, enhance diagnostic accuracy and patient outcomes. These advancements allow for better visualization of physiological processes, leading to more precise diagnoses. The introduction of new radiopharmaceuticals and improved detector technologies further boosts the efficacy of nuclear imaging. As healthcare facilities adopt these cutting-edge technologies, the demand for nuclear imaging devices is expected to rise. The market is likely to witness substantial growth as these innovations become more integrated into routine clinical practice, reflecting a shift towards more sophisticated imaging solutions.

Market Segment Insights

By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing)

In the Nuclear Imaging Devices Market, the application segment sees significant distribution with cardiology leading the charge. As the largest segment, cardiology utilizes nuclear imaging technologies primarily for diagnosing and managing cardiovascular diseases. Oncology follows closely, capturing a substantial share as healthcare providers increasingly adopt these devices for cancer detection and monitoring, thus establishing their importance in contemporary medical practice. Oncology is recognized as the fastest-growing segment within this landscape. Factors driving this growth include the rising incidence of cancer globally, along with ongoing advancements in nuclear imaging technologies that enhance diagnostic accuracy and treatment planning. Additionally, the increased focus on precision medicine encourages healthcare systems to invest more in advanced imaging modalities for oncology applications, further propelling this segment's growth trajectory.

Cardiology (Dominant) vs. Neurology (Emerging)

Cardiology stands out as the dominant application in the Nuclear Imaging Devices Market, owing to its extensive utilization in diagnosing heart conditions. The proficiency of nuclear imaging in revealing physiological details of the heart makes it indispensable for clinicians. It aids in assessing myocardial perfusion, cardiac function, and the detection of ischemic heart disease. In contrast, neurology is an emerging application area, catching the attention of healthcare providers. With advancements in imaging technology, neurologists are increasingly leveraging nuclear imaging for diagnosing complex neurological disorders, such as Alzheimer's disease and seizures. The growing awareness of neurological conditions and the development of specialized imaging agents contribute to neurology's potential to carve a larger market presence in the coming years.

By Product Type: Single Photon Emission Computed Tomography (Largest) vs. Positron Emission Tomography (Fastest-Growing)

In the Nuclear Imaging Devices Market, Single Photon Emission Computed Tomography (SPECT) holds a substantial share due to its wide application in diagnosing various conditions, particularly in cardiology and oncology. The technology is well-established and continues to be favored by healthcare providers, contributing to its market dominance. Positron Emission Tomography (PET), while currently smaller in market share, is experiencing rapid growth as advancements in technology enhance its capabilities, making it an increasingly attractive option for oncological diagnoses and functional imaging.

Imaging Technologies: SPECT (Dominant) vs. PET (Emerging)

Single Photon Emission Computed Tomography (SPECT) remains the dominant technology in the Nuclear Imaging Devices Market, known for its ability to produce detailed three-dimensional images of functional processes within the body. Its established presence in clinical settings allows for effective diagnostics and treatment monitoring. Conversely, Positron Emission Tomography (PET) is emerging as a vigorously growing modality, driven by innovations in imaging agents and technology that enhance its sensitivity and specificity. As PET systems evolve, they are becoming increasingly pivotal in areas such as oncology, neurology, and cardiology, capturing a growing market segment. Hybrid Imaging Systems continue to integrate these technologies, offering improved diagnostic capabilities.

By End Use: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the Nuclear Imaging Devices Market, hospitals command the largest share among end-use segments, capitalizing on their extensive resources and integrated healthcare services. Their capability to provide comprehensive patient care leads to significant demand for advanced nuclear imaging technologies. In contrast, diagnostic centers are quickly emerging as a vital player, thanks to their focused services and ability to adopt cutting-edge innovations that enhance diagnostic capabilities.

Hospitals (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals are the dominant sector in the Nuclear Imaging Devices Market, leveraging their established infrastructure to drive the adoption of nuclear imaging technologies. They benefit from a broad spectrum of imaging applications, ranging from routine diagnostics to advanced therapeutic procedures. Conversely, diagnostic centers represent the emerging aspect of this market, characterized by their specialized services and rapid adoption of the latest imaging technologies. This shift is fueled by increasing patient volumes and demand for accurate, timely diagnostics, with these centers often implementing state-of-the-art equipment to provide precise imaging solutions.

By Technology: Technetium-99m (Largest) vs. Gallium-68 (Fastest-Growing)

In the Nuclear Imaging Devices Market, Technetium-99m dominates the landscape, favored for its wide applications in diagnostic imaging. As a key radioisotope, it holds a significant market share, primarily because of its favorable physical properties, including a short half-life and ideal radiation characteristics. Cobalt-60, although still relevant, is less commonly used in this segment compared to Technetium-99m and Gallium-68, which has been gaining traction in recent years due to advancements in PET imaging techniques. The growth trends in this segment are largely driven by technological innovations and an increasing prevalence of chronic diseases requiring advanced diagnostic tools. Gallium-68 is emerging as a faster-growing segment, as its use in targeted therapies and precision medicine expands. Advancements in radiopharmaceuticals and a greater emphasis on personalized medicine are propelling the adoption rates of Gallium-68, indicating a shift towards advanced imaging technologies that enhance diagnostic accuracy.

Technology: Technetium-99m (Dominant) vs. Gallium-68 (Emerging)

Technetium-99m remains the dominant force within the Nuclear Imaging Devices Market, extensively utilized in various imaging procedures due to its favorable attributes like a short half-life and optimal gamma emission. Its established position in routine diagnostics has made it a preferred choice among healthcare facilities for producing high-quality images in a non-invasive manner. Conversely, Gallium-68 is recognized as an emerging force in the market, gaining momentum for its application in novel PET imaging techniques. Its unique properties allow for targeted molecular imaging, which is becoming increasingly popular in oncology and personalized medicine. As techniques for producing and utilizing Gallium-68 improve, its market presence is expected to grow, thereby challenging the long-standing dominance of Technetium-99m.

Get more detailed insights about Nuclear Imaging Devices Market Research Report - Forecast till 2035

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for nuclear imaging devices, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient care and diagnostic accuracy. The United States is the leading country in this market, with major players like GE Healthcare and Medtronic driving competition. Canada also contributes significantly, focusing on improving healthcare access and technology integration. The competitive landscape is characterized by continuous advancements in imaging technologies and strategic partnerships among key players, ensuring a robust market presence and innovation pipeline.

Europe : Emerging Market Dynamics

Europe is the second-largest market for nuclear imaging devices, accounting for about 30% of the global share. The region's growth is fueled by an aging population, rising healthcare expenditures, and increasing awareness of early disease detection. Regulatory frameworks, such as the European Medicines Agency guidelines, promote the safe and effective use of nuclear imaging technologies, further driving market expansion. Germany and France are the leading countries in this sector, with significant contributions from companies like Siemens Healthineers and Philips Healthcare. The competitive landscape is marked by innovation and collaboration among manufacturers, healthcare providers, and research institutions. This synergy fosters advancements in imaging technologies, enhancing diagnostic capabilities and patient outcomes.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is witnessing rapid growth in the nuclear imaging devices market, holding approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, rising incidences of chronic diseases, and a growing emphasis on advanced diagnostic techniques. Government initiatives aimed at enhancing healthcare infrastructure and accessibility are also significant catalysts for market growth. China and Japan are the leading countries in this market, with key players like Canon Medical Systems and Hitachi Medical Corporation making substantial contributions. The competitive landscape is evolving, with local manufacturers emerging alongside established global players. This dynamic environment fosters innovation and enhances the availability of advanced imaging solutions across the region.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the nuclear imaging devices market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of advanced diagnostic technologies, and government initiatives aimed at improving healthcare access. Regulatory bodies are also beginning to establish frameworks that support the adoption of nuclear imaging technologies, paving the way for future growth. Countries like South Africa and the UAE are leading the way in this sector, with a focus on enhancing healthcare infrastructure and attracting foreign investments. The competitive landscape is characterized by a mix of local and international players, creating opportunities for collaboration and innovation. As the market matures, the presence of key players is expected to expand, further driving growth in the region.

Key Players and Competitive Insights

The Nuclear Imaging Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic tools. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) emphasizes innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) focuses on strategic partnerships to expand its product offerings. Philips Healthcare (NL) is actively pursuing digital transformation initiatives, integrating AI capabilities into its imaging devices, thereby enhancing diagnostic accuracy and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological differentiation and customer-centric solutions.
In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The Nuclear Imaging Devices Market appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to emerge, yet the collective strength of major companies shapes the overall market dynamics, fostering an environment where innovation and strategic collaborations are paramount.
In August 2025, Siemens Healthineers (DE) announced a collaboration with a leading AI firm to develop next-generation imaging solutions that leverage machine learning algorithms. This strategic move is likely to enhance Siemens' product portfolio, positioning it as a leader in AI-integrated imaging technologies. The partnership underscores the growing importance of AI in improving diagnostic capabilities and streamlining workflows in healthcare settings.
In September 2025, GE Healthcare (US) launched a new line of nuclear imaging devices designed to improve patient comfort and reduce scan times. This initiative reflects GE's commitment to enhancing user experience while maintaining high diagnostic standards. The introduction of these devices may strengthen GE's competitive edge by addressing the evolving needs of healthcare providers and patients alike.
In July 2025, Philips Healthcare (NL) expanded its operations in Asia by establishing a new manufacturing facility in India. This strategic expansion is indicative of Philips' focus on localizing production to meet the growing demand for nuclear imaging devices in emerging markets. By enhancing its manufacturing capabilities in Asia, Philips is likely to improve its supply chain efficiency and reduce lead times, thereby gaining a competitive advantage in the region.
As of October 2025, the Nuclear Imaging Devices Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. These trends are reshaping competitive dynamics, with companies increasingly forming strategic alliances to leverage complementary strengths. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, efficient, and sustainable imaging solutions.

Key Companies in the Nuclear Imaging Devices Market include

Industry Developments

The Nuclear Imaging Devices Market has seen significant dynamics in recent months. In September 2023, Siemens Healthineers announced the launch of its new molecular imaging platform, aiming to enhance diagnostic capabilities and patient outcomes.

In August 2023, Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system with advanced imaging capabilities. This system is designed to improve diagnostic accuracy and workflow efficiency in clinical settings.

In June 2023, Canon Medical Systems unveiled enhancements to its Celesteion PET/CT system. These enhancements focused on faster acquisition times and improved image reconstruction algorithms, which cater to the increasing demand for high-efficiency imaging solutions in oncology.

Concurrently, GE Healthcare unveiled advancements in PET and SPECT technology, emphasizing a shift towards precision medicine in cancer treatment. Notable developments like these showcase the evolving landscape.

Major companies like Philips, Canon Medical Systems, and Hitachi Healthcare are navigating competitive challenges while striving to deliver cutting-edge nuclear imaging solutions. This continuous innovation drives the market forward.

Future Outlook

Nuclear Imaging Devices Market Future Outlook

The Nuclear Imaging Devices Market is projected to grow at a 4.38% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection.

New opportunities lie in:

  • Development of portable nuclear imaging devices for remote diagnostics.
  • Integration of AI for enhanced image analysis and interpretation.
  • Expansion into emerging markets with tailored product offerings.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in diagnostic imaging.

Market Segmentation

Nuclear Imaging Devices Market End Use Outlook

  • Hospitals
  • Diagnostic Centers
  • Research Institutions

Nuclear Imaging Devices Market Technology Outlook

  • Cobalt-60
  • Technetium-99m
  • Gallium-68

Nuclear Imaging Devices Market Application Outlook

  • Cardiology
  • Oncology
  • Neurology
  • Thyroid Function

Nuclear Imaging Devices Market Product Type Outlook

  • Single Photon Emission Computed Tomography
  • Positron Emission Tomography
  • Hybrid Imaging Systems

Report Scope

MARKET SIZE 2024 1.98(USD Billion)
MARKET SIZE 2025 2.067(USD Billion)
MARKET SIZE 2035 3.174(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.38% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT), Lantheus Medical Imaging (US)
Segments Covered Application, Product Type, End Use, Technology, Regional
Key Market Opportunities Advancements in artificial intelligence enhance diagnostic accuracy in the Nuclear Imaging Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Nuclear Imaging Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Nuclear Imaging Devices Market by 2035?

<p>The projected market valuation for the Nuclear Imaging Devices Market by 2035 is 3.174 USD Billion.</p>

What was the market valuation of the Nuclear Imaging Devices Market in 2024?

<p>The overall market valuation of the Nuclear Imaging Devices Market was 1.98 USD Billion in 2024.</p>

What is the expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035 is 4.38%.</p>

Which application segment had the highest valuation in the Nuclear Imaging Devices Market in 2024?

<p>In 2024, the Cardiology and Oncology application segments each had a valuation of 0.792 USD Billion.</p>

What are the key players in the Nuclear Imaging Devices Market?

<p>Key players in the Nuclear Imaging Devices Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.</p>

Which product type is projected to dominate the Nuclear Imaging Devices Market?

<p>The Single Photon Emission Computed Tomography product type is projected to dominate the Nuclear Imaging Devices Market with a valuation of 0.792 USD Billion in 2024.</p>

What is the valuation of the Diagnostic Centers segment in the Nuclear Imaging Devices Market?

<p>The Diagnostic Centers segment had a valuation of 0.66 USD Billion in 2024.</p>

Which technology segment is expected to see significant growth in the Nuclear Imaging Devices Market?

<p>The Technetium-99m technology segment is expected to see significant growth, with a valuation of 1.0 USD Billion in 2024.</p>

How does the market valuation of Research Institutions compare to that of Hospitals in 2024?

<p>In 2024, the market valuation for Hospitals was 0.99 USD Billion, while Research Institutions had a valuation of 0.33 USD Billion.</p>

What is the projected growth trend for the Nuclear Imaging Devices Market in the coming years?

<p>The Nuclear Imaging Devices Market is expected to grow steadily, reaching a valuation of 3.174 USD Billion by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Cardiology
    3. | | 4.1.2 Oncology
    4. | | 4.1.3 Neurology
    5. | | 4.1.4 Thyroid Function
    6. | 4.2 Healthcare, BY Product Type (USD Billion)
    7. | | 4.2.1 Single Photon Emission Computed Tomography
    8. | | 4.2.2 Positron Emission Tomography
    9. | | 4.2.3 Hybrid Imaging Systems
    10. | 4.3 Healthcare, BY End Use (USD Billion)
    11. | | 4.3.1 Hospitals
    12. | | 4.3.2 Diagnostic Centers
    13. | | 4.3.3 Research Institutions
    14. | 4.4 Healthcare, BY Technology (USD Billion)
    15. | | 4.4.1 Cobalt-60
    16. | | 4.4.2 Technetium-99m
    17. | | 4.4.3 Gallium-68
    18. | 4.5 Healthcare, BY Region (USD Billion)
    19. | | 4.5.1 North America
    20. | | | 4.5.1.1 US
    21. | | | 4.5.1.2 Canada
    22. | | 4.5.2 Europe
    23. | | | 4.5.2.1 Germany
    24. | | | 4.5.2.2 UK
    25. | | | 4.5.2.3 France
    26. | | | 4.5.2.4 Russia
    27. | | | 4.5.2.5 Italy
    28. | | | 4.5.2.6 Spain
    29. | | | 4.5.2.7 Rest of Europe
    30. | | 4.5.3 APAC
    31. | | | 4.5.3.1 China
    32. | | | 4.5.3.2 India
    33. | | | 4.5.3.3 Japan
    34. | | | 4.5.3.4 South Korea
    35. | | | 4.5.3.5 Malaysia
    36. | | | 4.5.3.6 Thailand
    37. | | | 4.5.3.7 Indonesia
    38. | | | 4.5.3.8 Rest of APAC
    39. | | 4.5.4 South America
    40. | | | 4.5.4.1 Brazil
    41. | | | 4.5.4.2 Mexico
    42. | | | 4.5.4.3 Argentina
    43. | | | 4.5.4.4 Rest of South America
    44. | | 4.5.5 MEA
    45. | | | 4.5.5.1 GCC Countries
    46. | | | 4.5.5.2 South Africa
    47. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 GE Healthcare (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Siemens Healthineers (DE)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Philips Healthcare (NL)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Canon Medical Systems (JP)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Elekta (SE)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Medtronic (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Hitachi Medical Corporation (JP)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Bracco Imaging (IT)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Lantheus Medical Imaging (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USE
    6. | 6.6 US MARKET ANALYSIS BY TECHNOLOGY
    7. | 6.7 CANADA MARKET ANALYSIS BY APPLICATION
    8. | 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY END USE
    10. | 6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
    13. | 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    14. | 6.14 GERMANY MARKET ANALYSIS BY END USE
    15. | 6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    16. | 6.16 UK MARKET ANALYSIS BY APPLICATION
    17. | 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE
    18. | 6.18 UK MARKET ANALYSIS BY END USE
    19. | 6.19 UK MARKET ANALYSIS BY TECHNOLOGY
    20. | 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
    21. | 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    22. | 6.22 FRANCE MARKET ANALYSIS BY END USE
    23. | 6.23 FRANCE MARKET ANALYSIS BY TECHNOLOGY
    24. | 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
    25. | 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    26. | 6.26 RUSSIA MARKET ANALYSIS BY END USE
    27. | 6.27 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
    28. | 6.28 ITALY MARKET ANALYSIS BY APPLICATION
    29. | 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    30. | 6.30 ITALY MARKET ANALYSIS BY END USE
    31. | 6.31 ITALY MARKET ANALYSIS BY TECHNOLOGY
    32. | 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
    33. | 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    34. | 6.34 SPAIN MARKET ANALYSIS BY END USE
    35. | 6.35 SPAIN MARKET ANALYSIS BY TECHNOLOGY
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY APPLICATION
    42. | 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    43. | 6.43 CHINA MARKET ANALYSIS BY END USE
    44. | 6.44 CHINA MARKET ANALYSIS BY TECHNOLOGY
    45. | 6.45 INDIA MARKET ANALYSIS BY APPLICATION
    46. | 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    47. | 6.47 INDIA MARKET ANALYSIS BY END USE
    48. | 6.48 INDIA MARKET ANALYSIS BY TECHNOLOGY
    49. | 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
    50. | 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    51. | 6.51 JAPAN MARKET ANALYSIS BY END USE
    52. | 6.52 JAPAN MARKET ANALYSIS BY TECHNOLOGY
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY END USE
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
    61. | 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
    62. | 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    63. | 6.63 THAILAND MARKET ANALYSIS BY END USE
    64. | 6.64 THAILAND MARKET ANALYSIS BY TECHNOLOGY
    65. | 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    67. | 6.67 INDONESIA MARKET ANALYSIS BY END USE
    68. | 6.68 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY END USE
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
    75. | 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    76. | 6.76 BRAZIL MARKET ANALYSIS BY END USE
    77. | 6.77 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
    78. | 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
    79. | 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    80. | 6.80 MEXICO MARKET ANALYSIS BY END USE
    81. | 6.81 MEXICO MARKET ANALYSIS BY TECHNOLOGY
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY END USE
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY END USE
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY END USE, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY END USE, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY END USE, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY END USE, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY END USE, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY END USE, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY END USE, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY END USE, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY END USE, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY END USE, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY END USE, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY END USE, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY END USE, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY END USE, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY END USE, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY END USE, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY END USE, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY END USE, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY END USE, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY END USE, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY END USE, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY END USE, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY END USE, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY END USE, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY END USE, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY END USE, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY END USE, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY END USE, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY END USE, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Cardiology
  • Oncology
  • Neurology
  • Thyroid Function

Healthcare By Product Type (USD Billion, 2025-2035)

  • Single Photon Emission Computed Tomography
  • Positron Emission Tomography
  • Hybrid Imaging Systems

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Research Institutions

Healthcare By Technology (USD Billion, 2025-2035)

  • Cobalt-60
  • Technetium-99m
  • Gallium-68
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓